ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,643Medicare Part D Prescriptions Filled, Including Refills

Rank: 204 out of 682

$784K Total Retail Price of All Prescriptions

Rank: 162 out of 682

562 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 10,155 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
AMLODIPINE BESYLATE 649 601 1 6
SIMVASTATIN 583 511 2 4
HYDROCODONE-ACETAMINOPHEN 520 354 S3 3 1
LOSARTAN POTASSIUM 447 413 4 20
ATORVASTATIN CALCIUM 408 389 5 11
LEVOTHYROXINE SODIUM 401 353 6 3
OMEPRAZOLE 391 314 7 5
LISINOPRIL 354 287 8 2
METOPROLOL SUCCINATE 264 233 9 16
HYDROCHLOROTHIAZIDE 195 165 10 12
GABAPENTIN 188 165 11 9
SERTRALINE HCL 186 165 12 24
WARFARIN SODIUM 174 173 13 13
METFORMIN HCL ER 173 137 14 68
ZOLPIDEM TARTRATE 164 154 15 21
CRESTOR 154 135 16 22
TRIAMTERENE-HCTZ 148 142 17 57
ATENOLOL 145 140 18 18
ALENDRONATE SODIUM 137 130 19 37
FUROSEMIDE 133 120 20 7
METOPROLOL TARTRATE 117 116 21 10
CIPROFLOXACIN HCL 102 90 22 58
PAROXETINE HCL 92 84 23 53
CARVEDILOL 88 75 24 23
ISOSORBIDE MONONITRATE ER 79 77 25 31
ALLOPURINOL 78 75 26 32
SYNTHROID 78 72 26 59
DIOVAN 77 75 28 42
PRAVASTATIN SODIUM 77 64 28 15
DONEPEZIL HCL 73 73 30 30
FLUOXETINE HCL 72 54 31 60
NEXIUM 71 66 32 19
DIGOXIN 68 66 33 46
CITALOPRAM HBR 65 65 34 17
METFORMIN HCL 62 48 35 8
LIPITOR 62 62 35 92
LANTUS 61 41 37 55
LOSARTAN-HYDROCHLOROTHIAZIDE 61 60 37 56
KLOR-CON M20 61 60 37 67
MELOXICAM 59 59 40 27
GLIPIZIDE ER 59 59 40 108
FLUTICASONE PROPIONATE 53 48 42 36
ACTOS 52 32 43 151
EXELON 52 52 43 104
TRAZODONE HCL 52 44 43 38
FELODIPINE ER 51 51 46 191
ADVAIR DISKUS 51 38 46 47
TRAMADOL HCL 51 45 46 26
CYMBALTA 50 47 49 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.